Article
Influence of MTHFR C677T polymorphism on methotrexate monotherapy discontinuation in rheumatoid arthritis patients: results from the GAPAID European project.
Clinical and experimental rheumatology - 1 Jan 2000
Uribarri María, Ruiz-Larrañaga Otsanda, Arteta David, Hernández Lorena, Alcaro Maria Claudia, Martínez Antonio, Escorza-Treviño Sergio, Estonba Andone, Migliorini Paola, Czirják László, del Amo Jokin
Abstract excerpt
OBJECTIVES: Methotrexate (MTX) is the most widely prescribed drug for rheumatoid arthritis (RA) patients, but 45% of them discontinue therapy within two years, either due to inefficacy or toxicity. Several authors have reported contradictory results related to C677T polymorphism in the MTHFR gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
